Table 4.

Detection of bcr/abl in SCID Mice at 18 Weeks After Injection

Control 4/5 (80%) 
CIK cells derived from bone marrow 1/7 (14.3%)3-150 
CIK cells derived from peripheral blood 1/6 (16.7%)3-150 
Control 4/5 (80%) 
CIK cells derived from bone marrow 1/7 (14.3%)3-150 
CIK cells derived from peripheral blood 1/6 (16.7%)3-150 

SCID mice were first injected subcutaneously with low-density CML cells containing 1.5 × 106 CD34+ cells per animal admixed with matrigel. Four weeks later some animals received 4 × 107 autologous CIK cells either derived from bone marrow or peripheral blood. Animals were killed 14 weeks later and analyzed for the presence of bcr/abl transcripts by RT-PCR from RNA extracted from PB, bone marrow, and spleen.

F3-150

Indicates that the CIK-treated animals were less likely to have positive RT-PCR results (P = .02).

Close Modal

or Create an Account

Close Modal
Close Modal